CARLSMED INC (CARL) Stock Price & Overview
NASDAQ:CARL • US14280C1053
Current stock price
The current stock price of CARL is 11.4 USD. Today CARL is up by 0.35%. In the past month the price increased by 5.95%.
CARL Key Statistics
- Market Cap
- 304.722M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.83
- Dividend Yield
- N/A
CARL Stock Performance
CARL Stock Chart
CARL Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to CARL.
CARL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CARL. CARL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
CARL Earnings
On February 25, 2026 CARL reported an EPS of -0.32 and a revenue of 15.16M. The company beat EPS expectations (26.36% surprise) and beat revenue expectations (2.52% surprise).
CARL Forecast & Estimates
11 analysts have analysed CARL and the average price target is 19.79 USD. This implies a price increase of 73.58% is expected in the next year compared to the current price of 11.4.
For the next year, analysts expect an EPS growth of -30.83% and a revenue growth -6.41% for CARL
CARL Groups
Sector & Classification
CARL Financial Highlights
Over the last trailing twelve months CARL reported a non-GAAP Earnings per Share(EPS) of -1.83. The EPS decreased by -31.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -34.45% | ||
| ROE | -43.55% | ||
| Debt/Equity | 0.14 |
CARL Ownership
CARL Latest News, Press Relases and Analysis
CARL Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 18.81 | 187.913B | ||
| ISRG | INTUITIVE SURGICAL INC | 46.2 | 170.203B | ||
| SYK | STRYKER CORP | 22.27 | 129.047B | ||
| BSX | BOSTON SCIENTIFIC CORP | 19.77 | 101.721B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.52 | 49.099B | ||
| IDXX | IDEXX LABORATORIES INC | 38.71 | 45.48B | ||
| BDX | BECTON DICKINSON AND CO | 11.69 | 45.453B | ||
| RMD | RESMED INC | 18.8 | 33.857B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.69 | 32.053B | ||
| DXCM | DEXCOM INC | 25.27 | 25.116B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.99 | 18.115B | ||
| HOLX | HOLOGIC INC | 15.3 | 16.79B | ||
| PODD | INSULET CORP | 34 | 16.619B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CARL
Company Profile
Carlsmed, Inc. engages in the development of AI based technology solutions to the medical industry. The company is headquartered in Carlsbad, California. The company went IPO on 2025-07-23. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights intended to improve the digital surgical planning process. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.
Company Info
IPO: 2025-07-23
CARLSMED INC
1800 Aston Ave., Suite 100
Carlsbad CALIFORNIA US
Employees: 100
Phone: 17607661923
CARLSMED INC / CARL FAQ
What does CARLSMED INC do?
Carlsmed, Inc. engages in the development of AI based technology solutions to the medical industry. The company is headquartered in Carlsbad, California. The company went IPO on 2025-07-23. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights intended to improve the digital surgical planning process. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.
Can you provide the latest stock price for CARLSMED INC?
The current stock price of CARL is 11.4 USD. The price increased by 0.35% in the last trading session.
Does CARL stock pay dividends?
CARL does not pay a dividend.
What is the ChartMill rating of CARLSMED INC stock?
CARL has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Is CARLSMED INC (CARL) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CARL.
What is CARLSMED INC worth?
CARLSMED INC (CARL) has a market capitalization of 304.72M USD. This makes CARL a Small Cap stock.
What is the outstanding short interest for CARLSMED INC?
The outstanding short interest for CARLSMED INC (CARL) is 4.51% of its float.